The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Peri-operative morbidity and mortality in a modern series of patients treated with cytoreductive nephrectomy (CN) at five centers.
 
Ashanda Rosetta Patrice Esdaille
No Relationships to Disclose
 
Jose A. Karam
Stock and Other Ownership Interests - Alimera Sciences; MedTek
Honoraria - Pfizer; Roche/Genentech
Consulting or Advisory Role - Pfizer; Roche/Genentech
Research Funding - Merck (Inst); Mirati Therapeutics (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche/Genentech
 
Philippe E. Spiess
Leadership - Global Society of Rare Genitourinary Tumors; NCCN
Honoraria - UptoDate
Other Relationship - NCCN
(OPTIONAL) Uncompensated Relationships - Moffitt Cancer Center
 
Jay D. Raman
No Relationships to Disclose
 
Daniel D. Shapiro
No Relationships to Disclose
 
Pranav Sharma
No Relationships to Disclose
 
Wade J. Sexton
No Relationships to Disclose
 
Logan Zemp
No Relationships to Disclose
 
Alyssa Bilotta
No Relationships to Disclose
 
Glenn O. Allen
No Relationships to Disclose
 
Surena F. Matin
Honoraria - Taris BioMedical; Urogen pharma
Consulting or Advisory Role - C-SATS; Peloton Therapeutics; QED Therapeutics; Taris BioMedical; Urogen pharma
Research Funding - AT&T; Specialized Program in Oncology Research (SPORE)
Travel, Accommodations, Expenses - MSD
 
Christopher G. Wood
No Relationships to Disclose
 
Edwin J Abel
No Relationships to Disclose